Fresh off raising $1.8M, Chapel Hill startup preps for $8 million

Chapel Hill-based startup Renovion – which is developing a nebulized therapy called Arina-1 for the treatment of lung transplant patients– has its eyes on submitting a New Drug Application to the U.S. Food and Drug Administration in early 2019, according to chief executive officer Dan Copeland. The company has raised more than $ 1.8 million of a planned $2 million offering to “fund pre-clinical and clinical programs,” he says, and is looking to raise another $8 million in the lead up to the…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news